EPISODE · Mar 25, 2018 · 26 MIN
The FDA’s gag rule on off-label treatments
Michael Cannon, director of health policy studies for the Cato Institute, talks about the gag rule that places restrictions on discussing legal uses of drugs for off-label purposes, as well as a bill that would make trial drugs available to terminally ill patients.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Embed this episode
NOW PLAYING
The FDA’s gag rule on off-label treatments
0:00
26:09
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Of Consuming Interest?
This episode is 26 minutes long.
When was this Of Consuming Interest episode published?
This episode was published on March 25, 2018.
Can I download this Of Consuming Interest episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!